Aristotle Capital Boston LLC Invests $3.08 Million in Healthpeak Properties, Inc. (NYSE:DOC)

Aristotle Capital Boston LLC purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 151,678 shares of the real estate investment trust's stock, valued at approximately $3,075,000.

Several other hedge funds and other institutional investors have also made changes to their positions in DOC. Mercer Global Advisors Inc. ADV raised its position in shares of Healthpeak Properties by 29.4% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 38,379 shares of the real estate investment trust's stock worth $778,000 after purchasing an additional 8,726 shares during the period. Kapitalo Investimentos Ltda acquired a new stake in Healthpeak Properties during the 4th quarter worth approximately $46,000. Northern Trust Corp raised its holdings in Healthpeak Properties by 32.6% during the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after buying an additional 2,590,530 shares during the period. Susquehanna Fundamental Investments LLC acquired a new position in shares of Healthpeak Properties in the fourth quarter valued at approximately $16,450,000. Finally, Nebula Research & Development LLC increased its position in shares of Healthpeak Properties by 80.5% during the fourth quarter. Nebula Research & Development LLC now owns 64,110 shares of the real estate investment trust's stock worth $1,300,000 after acquiring an additional 28,595 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on DOC. Evercore ISI cut their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. StockNews.com cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Thursday, May 1st. Morgan Stanley upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. Argus restated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a report on Tuesday, April 29th. Finally, Robert W. Baird decreased their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, Healthpeak Properties has a consensus rating of "Moderate Buy" and a consensus target price of $23.42.

Healthpeak Properties Stock Performance

Healthpeak Properties stock traded down $0.18 during midday trading on Wednesday, hitting $17.26. The company's stock had a trading volume of 9,862,825 shares, compared to its average volume of 4,933,957. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company has a market cap of $11.99 billion, a price-to-earnings ratio of 49.31, a PEG ratio of 2.17 and a beta of 1.05. Healthpeak Properties, Inc. has a 1-year low of $17.22 and a 1-year high of $23.26. The company has a 50-day moving average price of $19.26 and a two-hundred day moving average price of $20.35.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The company had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same period in the previous year, the business earned $0.45 earnings per share. The firm's quarterly revenue was up 15.9% on a year-over-year basis. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a dividend, which was paid on Wednesday, April 30th. Investors of record on Friday, April 18th were given a dividend of $0.1017 per share. The ex-dividend date was Thursday, April 17th. This represents a yield of 6.5%. Healthpeak Properties's dividend payout ratio is 305.00%.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker acquired 11,337 shares of Healthpeak Properties stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the purchase, the chief executive officer now directly owns 201,863 shares of the company's stock, valued at $3,568,937.84. This represents a 5.95 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director John T. Thomas bought 4,200 shares of the firm's stock in a transaction on Monday, April 28th. The stock was acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the transaction, the director now owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.23% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.